The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
On May 29, 2024, the Food and Drug Administration granted accelerated approval to selpercatinib (Retevmo,…
Tumour cells often hijack normal physiological processes to support their growth, exploiting proteins that are…
New research out of VCU Massey Comprehensive Cancer Center, USA, — recently published in Drug…
On May 30, 2024, the US Food and Drug Administration approved lisocabtagene maraleucel (Breyanzi, Juno…
According to the WHO, colorectal cancer (CRC) is the third most common cancer worldwide, accounting for…
NSCLC is the leading cause of cancer deaths globally, with EGFR mutations being a common…
A team of cancer researchers, led by the University of Houston, USA, has discovered a…
Breast cancer is a major cause of patient deaths and often leads to significant life…
It’s important to ensure that care provided at US hospitals that predominantly serve Black and…
Vaccinia viruses are therapeutic tools with different biomedical applications depending on the susceptibility characteristics. For…